Clinical and evoked potential changes in acute transverse myelitis following methyl prednisolone

Spinal Cord

Volumn 37, Issue 9, 1999, Pages 658-662

  Kalita, J ^b   Guptar, P M ^b   Misra, U K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE

Author keywords

Corticosteroid; Evoked potentials; Prognosis; Transverse myelitis

Indexed keywords

METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ARM; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JOINT; LEG; MALE; MEDIAN NERVE; MOTOR NERVE CONDUCTION; MUSCLE WEAKNESS; MYELITIS; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; SCHOOL CHILD; TIBIAL NERVE; TIBIALIS ANTERIOR MUSCLE;

EID: 0032870863     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100894     Document Type: Article

References (14)

1. 1 Dawson DM, Potts FM. Acute nontraumatic myelopathies. In: Woolsey RM and Young RR (eds). Neurology Clinics. Disorders of spinal cord. WB Saunders, Philadelphia 1991; pp 551-603.
2. 2 Ropper AH, Miett T, Chiappa KH. Absence of evoked potential abnormalities in acute transverse myelopathy. Neurology (Minneap) 1982; 32: 80-82.
3. 3 Misra UK, Kalita J, Kumar S. A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci 1996; 138: 150-156.
4. 4 Dowling PC, Busch VV, Cook SD. Possible beneficial effect of high dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology 1980; 30: 33-36.
5. 5 Choi KH et al. Idiopathic transverse myelitis. MR characteristics. AJNR 1996; 17: 1151-1160.
6. 6 Jeffery DR, Mandler RN, Davis L. Transverse myelitis retrospective analysis of 33 cases with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993; 50: 532-535.
7. 7 Penn RD et al. Intrathecal baclofen for severe spinal spasticity. New Engl J Med 1989; 320: 1517-1521.
8. 8 Misra UK, Kalita J. Motor evoked potential is useful for monitoring the effect of collar therapy in cervical spondylotic myelopathy. J Neurol Sci 1998; 154: 222-228.
9. 9 Thompson PD et al. Examination of motor functions in lesions of spinal cord by the stimulation of the motor cortex. Ann Neurol 1987; 21: 389-396.
10. 10 Hoffman HL. Acute necrotic myelopathy. Brain 1955; 78: 377-393.
11. 11 Bantivolgia M. The anatomical organisation of corticospinal connections. In: Rossini PM and Marsden CD (eds). Non invasive stimulation of brain and spinal cord. Fundamentals and clinical applications. Allen R Liss, New York 1998: pp 1-22.
12. 12 Milligan NM, Newcombe R, Compron DA. A double blind control trial of high dose methyl prednisolone in patients with multiple sclerosis I. Clinical effects. J Neurol Neurosurg Psychiat 1987; 50: 511-516.
13. 13 Barnes MP et al. Intravenous methyl prednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiat 1985; 48: 157-159.
14. 14 Altrocchi PH, Calif PA. Acute transverse myelopathy. Arch Neurol 1963; 9: 111-119.